Presentation is loading. Please wait.

Presentation is loading. Please wait.

Aspects of HIV in Denmark Jane Agergaard, MD, PhD Department of Infectious Diseases Aarhus University Hospital Skejby Denmark.

Published byRodger Logan Modified over 8 years ago

Similar presentations

Presentation on theme: "Aspects of HIV in Denmark Jane Agergaard, MD, PhD Department of Infectious Diseases Aarhus University Hospital Skejby Denmark."— Presentation transcript:

1 Aspects of HIV in Denmark Jane Agergaard, MD, PhD Department of Infectious Diseases Aarhus University Hospital Skejby Denmark

2 Epidemiology 250-300 new cases pr. year Constant during 10 years 70% men, <50% ethnic Danes MSM transmission in Denmark Hetero-sexual transmission in immigrants Cohort of 4.500 gets older! More co-morbidities Danish national patient register/CPR register Danish HIV cohort database 6000 pts, VL, CD4, ART regimens » E.g. » Helleberg M, Clin Infect Dis. 2013 Jul;57(2):314-21. doi: 10.1093/cid/cit232. Epub 2013 Apr 10. CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV. Helleberg MClin Infect Dis. » Lohse N, Clin Infect Dis. 2006 Jan 1;42(1):136-44. Epub 2005 Nov 30. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study. Lohse NClin Infect Dis. » Jensen-Fangel S et al, AIDS. 2004 Jan 2;18(1):89-97., Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. Jensen-Fangel SAIDS.

3 Testing Pregnant women/Anonymous GP/hospitalisation Travellers/immigrants/MSM Symptoms not explained Contact tracing No legislation in DK 1 HIV pos. found for every 4 index case Counselling means finding more » HIV and partner notification in Denmark, Rodkjaer LO, Ostergaard LJ, Frydenberg M. Infektionsmedicinsk afdeling Q, Arhus Universitetshospital, Skejby, DK-8200 Arhus. ROL@sks.aaa.dk

4 Youth group Background The kids were lonely and sad Tabus and personal problems Time at diagnose – traumatic event Outpatients clinic Lifelong treatment Adherence Living with the disease as a secret Anxiety- stress – depression Sexually transmitted disease/Control your sex life Members 15 - 25 years of age Majority with another ethnic background than Danish Heterosexual, homosexual, bisexual Born with HIV or infected in youth

5 Activities youth group Weekend tour /Youth day at outpatients Education Activities » walk, paint, sessions with guest instructors aso. Socialising/Informal talks with friends and adults Confidentiality Blood tests and consultations Adherence improve » Others take same medication » If adherent no need for regular consultations

Download ppt "Aspects of HIV in Denmark Jane Agergaard, MD, PhD Department of Infectious Diseases Aarhus University Hospital Skejby Denmark."

Similar presentations

Denmark; 5.5 mill. inh.. 5,773 hiv patients Copenhagen 1.2 mill. inh. – 4.059 pt (70.4 %) Aarhus 311,000 inh. – 654 pt (11.3 %) Odense 190,000 inh.

Denmark; 5.5 mill. inh.. 5,773 hiv patients Copenhagen 1.2 mill. inh. – pt (70.4 %) Aarhus 311,000 inh. – 654 pt (11.3 %) Odense 190,000 inh.
Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.

Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County 2008-2010 Shoshanna Nakelsky, MPH Division of HIV and.

Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.

Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.

STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Field Based Treatment of Chlamydia and Gonorrhea Nilmarie Guzmán,MD & Michael Sands,MD University of Florida/Jacksonville and the Duval County Health Department.

Field Based Treatment of Chlamydia and Gonorrhea Nilmarie Guzmán,MD & Michael Sands,MD University of Florida/Jacksonville and the Duval County Health Department.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,

HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.

The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Late HIV Diagnoses, Georgia,

Late HIV Diagnoses, Georgia,
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.

Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Concordance of HIV surveillance and medical record data: What do CD4 and viral loads not tell us about linkage to HIV care? Charu Sabharwal, MD MPH Medical.

Concordance of HIV surveillance and medical record data: What do CD4 and viral loads not tell us about linkage to HIV care? Charu Sabharwal, MD MPH Medical.
THE EPIDEMIOLOGY OF HIV/AIDS. HIV/AIDS – USA 2009 Living with HIV/AIDS = 1.2 million Incidence = 56,000/year MSM = 53% Heterosexuals = 31% IDUs.

THE EPIDEMIOLOGY OF HIV/AIDS. HIV/AIDS – USA 2009 Living with HIV/AIDS = 1.2 million Incidence = 56,000/year MSM = 53% Heterosexuals = 31% IDUs.
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.

Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
HIV and STI Department - Centre for Infections Predictors of non-AIDS related death in a national cohort of HIV-diagnosed adults Meaghan Kall, Ruth Smith,

HIV and STI Department - Centre for Infections Predictors of non-AIDS related death in a national cohort of HIV-diagnosed adults Meaghan Kall, Ruth Smith,
National Healthcare Quality and Disparities Report

National Healthcare Quality and Disparities Report
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.

A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.

Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Long term follow up of the UK and Ireland paediatric cohort as teenagers transition to adult services Ali Judd, 1 Caroline Foster, 2 Caroline Sabin, 3.

Long term follow up of the UK and Ireland paediatric cohort as teenagers transition to adult services Ali Judd, 1 Caroline Foster, 2 Caroline Sabin, 3.
Www.aids2012.org Washington D.C., USA, JULY 22-27 2012 Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.

Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.

Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.

Similar presentations

Ads by Google